Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cancer Letters

• Publication date

  2014-07-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2014.04.004PMID 24752068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor.

  2013cited by this paper
• Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

  2013cited by this paper
• Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity

  2012cited by this paper
• Neuropilins: expression and roles in the epithelium

  2012cited by this paper
• Anti-Neuropilin-1 (MNRP1685A): Unexpected Pharmacokinetic Differences Across Species, from Preclinical Models to Humans

  2012cited by this paper
• Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cells.

  2012cited by this paper
• Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.

  2010cited by this paper
• Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction

  2010cited by this paper
• C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration

  2009cited by this paper
• Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

  2008cited by this paper
• Blocking neuropilin-2 function inhibits tumor cell metastasis.

  2008cited by this paper
• FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects

  2008cited by this paper
• Development of a chemiluminescent screening assay for detection of vascular endothelial growth factor receptor 1 ligands.

  2007cited by this paper
• Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.

  2007cited by this paper
• Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.

  2007cited by this paper
• Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.

  2007cited by this paper
• Structural basis for ligand and heparin binding to neuropilin B domains

  2007cited by this paper
• Neuropilins in neoplasms: expression, regulation, and function.

  2006cited by this paper
• Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling*

  2006cited by this paper
• Lessons from phase III clinical trials on anti-VEGF therapy for cancer

  2006cited by this paper
• A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells

  2005cited by this paper
• In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1.

  2004cited by this paper
• UCSF Chimera—A visualization system for exploratory research and analysis

  2004cited by this paper
• Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine.

  2003cited by this paper
• VEGF and the quest for tumour angiogenesis factors

  2002cited by this paper
• Neuropilin is a receptor for the axonal chemorepellent Semaphorin III.

  1997cited by this paper
• Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins.

  1994cited by this paper

• Structure-based virtual screening and post-docking analysis of a D-amino acid oxidase inhibitor targeting the molecular surface.

  2025cites this paper
• Small molecule inhibitors of the co-receptor neuropilin-1ni.

  2025cites this paper
• Neuropilin Antagonists (NRPas) Block the Phosphorylation of the Cancer Therapeutic Key Factor p38α Kinase Triggering Cell Death

  2025influential citation
• Chirality and Rigidity in Triazole-Modified Peptidomimetics Interacting with Neuropilin-1

  2024cites this paper
• Peptidomimetic inhibitors of the VEGF-A165/NRP-1 complex obtained by modification of the C-terminal arginine

  2024cites this paper
• Semaphorins in tumor microenvironment: Biological mechanisms and therapeutic progress.

  2024cites this paper
• Identification of Four New Chemical Series of Small Drug‐Like Natural Products as Potential Neuropilin‐1 Inhibitors by Structure‐Based Virtual Screening: Pharmacophore‐Based Molecular Docking and Dynamics Simulation

  2023cites this paper
• Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors.

  2023cites this paper
• Endothelial neuropilin-1 and neuropilin-2 are essential for tumour angiogenesis

  2022cites this paper
• Neuropilin (NRPs) Related Pathological Conditions and Their Modulators

  2022cites this paper
• Endothelial VEGFR Coreceptors Neuropilin-1 and Neuropilin-2 Are Essential for Tumor Angiogenesis

  2022cites this paper
• Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1

  2022cites this paper
• Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry

  2021cites this paper
• Selection and characterization of specific nanobody against neuropilin-1 for inhibition of angiogenesis.

  2020cites this paper
• Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine

  2020cites this paper
• [Neuropilins: relevant therapeutic targets to improve the treatment of cancers].

  2020cites this paper
• In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein

  2020cites this paper
• Urea-Peptide Hybrids as VEGF-A165/NRP-1 Complex Inhibitors with Improved Receptor Affinity and Biological Properties

  2020cites this paper
• Targeting VEGF-neuropilin interactions: a promising antitumor strategy.

  2019cites this paper
• Neuropilin-1 peptide-like ligands with proline mimetics, tested using the improved chemiluminescence affinity detection method.

  2019cites this paper
• Identification of a pyrimidinetrione derivative as the potent DprE1 inhibitor by structure-based virtual ligand screening.

  2019cites this paper
• Triazolopeptides Inhibiting the Interaction between Neuropilin-1 and Vascular Endothelial Growth Factor-165

  2019cites this paper
• Urea moiety as amide bond mimetic in peptide-like inhibitors of VEGF-A165/NRP-1 complex.

  2019cites this paper
• Synthesis, 3D-structure and stability analyses of NRPa-308, a new promising anti-cancer agent.

  2019cites this paper
• Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification.

  2019cites this paper
• Architecture and hydration of the arginine‐binding site of neuropilin‐1

  2018cites this paper
• Modular synthesis of new C-aryl-nucleosides and their anti-CML activity.

  2018cites this paper
• NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model.

  2018cites this paper
• NRP-2 in tumor lymphangiogenesis and lymphatic metastasis.

  2018cites this paper
• New peptide MY1340 revert the inhibition effect of VEGF on dendritic cells differentiation and maturation via blocking VEGF‐NRP‐1 axis and inhibit tumor growth in vivo

  2018cites this paper
• Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.

  2018cites this paper
• NRP‐1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival

  2018cites this paper
• Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells

  2018cites this paper
• Small Molecule Inhibitors Targeting New Targets of Protein-Protein Interactions

  2018cites this paper
• In silico structure-based approaches to discover protein-protein interaction-targeting drugs.

  2017cites this paper
• Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1

  2017cites this paper
• Conformational latitude – activity relationship of KPPR tetrapeptide analogues toward their ability to inhibit binding of vascular endothelial growth factor 165 to neuropilin‐1

  2017cites this paper
• Identification of Peptidic Antagonists of Vascular Endothelial Growth Factor Receptor 1 by Scanning the Binding Epitopes of Its Ligands.

  2017cites this paper
• Docking Screens for Novel Ligands Conferring New Biology.

  2016cites this paper
• NRP1 function and targeting in neurovascular development and eye disease

  2016cites this paper
• VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumors

  2016cites this paper
• Current drug design to target the Semaphorin/Neuropilin/Plexin complexes

  2016cites this paper
• Carbohydrate-based peptidomimetics targeting neuropilin-1: Synthesis, molecular docking study and in vitro biological activities.

  2016cites this paper
• Discoidin Domains as Emerging Therapeutic Targets.

  2016cites this paper
• Addressing the Issues of Non-isotropy and Non-additivity in the Development of Quantum Chemistry-Grounded Polarizable Molecular Mechanics

  2015cites this paper
• Rational design of protein–protein interaction inhibitors

  2015cites this paper
• Novel expression of Neuropilin 1 on human tumor-infiltrating lymphocytes in colorectal cancer liver metastases

  2015cites this paper
• New Peptides Structurally Related to VEGF-A165 Exon-7 and -8 Encoded Domains Antagonize Its Binding to NRP-1 and VEGF-R1

  2015cites this paper
• Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas.

  2015cites this paper
• Synthesis and structure-activity relationship of non-peptidic antagonists of neuropilin-1 receptor.

  2014cites this paper